Hematologic, Blood, Lymphoma & Leukemia Cancer | News & Articles

Hematologic Cancers

Hematologic Cancers News & Features
Cancer Management and Research

Carfilzomib for Relapsed and Refractory Multiple Myeloma

[Cancer Management and Research] A review of data from clinical trials on the use of carfilzomib, a second-generation PI, in the treatment of R/R multiple myeloma, as well as ongoing studies and prescribing advice.
Next post in Hematologic Cancers